Is encapsulating peritoneal sclerosis a threatening issue in continuous ambulatory peritoneal dialysis? The Japanese experience

Masaaki Nakayama, Masato Ikeda, Naohiko Katoh, Keitaro Yokoyama, Hiroyasu Yamamoto, Yoshindo Kawaguchi, Tatsuo Hosoya, Hideharu Mukai

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

Encapsulating peritoneal sclerosis (EPS) is undoubtedly the most serious complication of continuous ambulatory peritoneal dialysis treatment in Japan, with a mortality rate ranging from about 39% to 49% in reported series. Cases of EPS have been linked to long-term peritoneal dialysis, and limitations on renal transplantation in Japan mean that most Japanese patients have to accept long-term dialysis therapy, which is a critical problem. Treatment alternatives for EPS include total parenteral nutrition, prednisolone administration, and surgical approaches, all of which have varying success rates. Additional therapeutic and new preventive measures have to be established for EPS.

Original languageEnglish
Pages (from-to)S132-S133
JournalPeritoneal Dialysis International
Volume23
Issue numberSUPPL. 2
DOIs
Publication statusPublished - 2003 Jan 1

Keywords

  • Continuous ambulatory peritoneal dialysis
  • EPS
  • Encapsulating peritoneal sclerosis
  • Incidence
  • Treatment

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Is encapsulating peritoneal sclerosis a threatening issue in continuous ambulatory peritoneal dialysis? The Japanese experience'. Together they form a unique fingerprint.

Cite this